PT  - JOURNAL ARTICLE
AU  - Habiba Hassouna
AU  - Abhishek Deshpande
TI  - Clinicians should assess the benefits and risks of using bezlotoxumab for reducing the risk of recurrent <em>Clostridium difficile</em> infection
AID  - 10.1136/ebmed-2017-110722
DP  - 2017 Aug 01
TA  - Evidence Based Medicine
PG  - 150--151
VI  - 22
IP  - 4
4099  - http://ebm.bmj.com/content/22/4/150.short
4100  - http://ebm.bmj.com/content/22/4/150.full
SO  - Evid Based Med2017 Aug 01; 22